Funding agencies: This study was supported by CHDI Foundation, Inc.
HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease1,2,3
Version of Record online: 7 JUL 2014
© 2014 International Parkinson and Movement Disorder Society
Volume 29, Issue 10, pages 1281–1288, September 2014
How to Cite
Stout, J. C., Queller, S., Baker, K. N., Cowlishaw, S., Sampaio, C., Fitzer-Attas, C., Borowsky, B. and the HD-CAB Investigators (2014), HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease1,2,3. Mov. Disord., 29: 1281–1288. doi: 10.1002/mds.25964
Relevant conflicts of interest/financial disclosures: CHDI Foundation, Inc. is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. Dr. Stout has received funding from CHDI Foundation which relates to this research. She is also a director of Stout Neuropsych Pty Ltd. Dr. Queller has received funding from the CHDI Foundation and Monash University, both of which relate to this research. Drs. Sampaio, Fitzer-Attas, and Borowsky are employed by CHDI Management, Inc., which provides advisory services to CHDI Foundation.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 10 SEP 2014
- Version of Record online: 7 JUL 2014
- Manuscript Accepted: 13 MAY 2014
- Manuscript Received: 20 MAR 2014
Additional Supporting Information may be found in the online version of this article at the publisher's web-site.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.